Lesson plan
Polpharma
Zakłady Farmaceutyczne Polpharma S.A. ("Pharmaceutical Works Polpharma"), commonly known as Polpharma, is a Polish pharmaceutical company headquartered in Starogard Gdański. It is the largest Polish manufacturer of medicines and active pharmaceutical ingredients (APIs) and the leader of the Polish pharmaceutical market in terms of both volume and value of sales. The company is the parent entity of the Polpharma Group, which operates in Western Europe (including through Farmaprojects in Spain and 089 Pharm in Germany ), Central and Eastern Europe and Central Asia, with the group's management headquartered in Warsaw . The group manufactures around 400 million packs of medicines annually, sold in more than 40 countries . In 2025 the company generated sales revenue of PLN 4.93 billion and a net profit of PLN 946 million . The group is owned by Jerzy Starak . Since 1 January 2026 the president (CEO) of the Polpharma Group has been Sebastian Szymanek, who has also served as president of the management board of Zakłady Farmaceutyczne Polpharma S.A. since 2021 .
Article summary
Zakłady Farmaceutyczne Polpharma S.A. ("Pharmaceutical Works Polpharma"), commonly known as Polpharma, is a Polish pharmaceutical company headquartered in Starogard Gdański. It is the largest Polish manufacturer of medicines and active pharmaceutical ingredients (APIs) and the leader of the Polish pharmaceutical market in terms of both volume and value of sales. The company is the parent entity of the Polpharma Group, which operates in Western Europe (including through Farmaprojects in Spain and 089 Pharm in Germany ), Central and Eastern Europe and Central Asia, with the group's management headquartered in Warsaw . The group manufactures around 400 million packs of medicines annually, sold in more than 40 countries . In 2025 the company generated sales revenue of PLN 4.93 billion and a net profit of PLN 946 million . The group is owned by Jerzy Starak . Since 1 January 2026 the president (CEO) of the Polpharma Group has been Sebastian Szymanek, who has also served as president of the management board of Zakłady Farmaceutyczne Polpharma S.A. since 2021 .
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.